Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NeuroMetrix to Participate in the Benchmark Micro Cap Discovery Conference

NURO

NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be participating in the one-on-one Benchmark Micro Cap Discovery Conference which will be held at the Palmer House Hilton, Chicago, IL on Thursday, December 11, 2014 from 8:00am to 2:30pm. Dr. Gozani intends to provide a business update and discuss development progress on Quell™, the Company’s over the counter wearable pain relief device which will be unveiled at the International Consumer Electronics Show (CES) in Las Vegas in January 2015. To schedule a one-on-one meeting with Dr. Gozani please e-mail vcuratola@benchmarkcompany.com or contact your Benchmark representative.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. For more information, please visit http://www.NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today